Petros Grivas: Congratulations Neeraj Agarwal Neal Shore and all authors!

Petros Grivas shared a post by Neeraj Agarwal, on X:

“Congratulations Neeraj Agarwal Neal Shore and all authors! Very important paper!”

Quoting Neeraj Agarwal‘s post:

“Just in European Urology Oncology Expert guidance (by modified Delphi panel method) on management of AEs in patients with prostate cancer receiving combination PARPi + ARPI (NHT) treatment.”

Source: Petros Grivas/X and Neeraj Agarwal/X

Dr. Petros Grivas, a board-certified medical oncologist, serves as Clinical Director of the Genitourinary Cancers Program at the University of Washington and Seattle Cancer Care Alliance.

He’s an Associate Professor at the Dept. of Medicine and Associate Member at Fred Hutchinson Cancer Research Center since January 2018. With extensive training and experience, he’s led clinical trials, contributing to FDA approvals for bladder/urothelial cancer treatments.

Neeraj Agarwal is a Professor of Medicine, and a Presidential Endowed Chair of Cancer Research at the Huntsman Cancer Institute (HCI), University of Utah. He also directs the Genitourinary Oncology (GU) Program, and the Center of Investigational Therapeutics (CIT) at the HCI. Dr. Agarwal is an Advisor to the Oncology Drug Advisory Committee and the United States Food and Drug Administration, leads early therapeutics in the SWOG genitourinary cancers committee, and is the Chief Editor of ASCO Daily News.